The relationship between stereotypical movement disorder and neuroinflammation

Area of Science:

• Neuroscience
• Immunology
• Developmental Pediatrics

Background:

• Stereotypic movement disorder (SMD) often co-occurs with autism spectrum disorder (ASD), but its underlying mechanisms are unclear.
• Neuroinflammation is increasingly implicated in the development of neurodevelopmental disorders.
• Interleukin-1β (IL-1β) and interleukin-6 (IL-6) are key inflammatory cytokines.

Purpose of the Study:

• To investigate the role of IL-1β and IL-6 in the pathophysiology of primary SMD and ASD.
• To examine the association between these cytokines and the severity of stereotyped behaviors.

Main Methods:

• Cross-sectional study of children and adolescents (6-18 years) in four groups: primary SMD, ASD with SMD, ASD without SMD, and healthy controls.
• Standardized diagnostic and behavioral assessments were used.
• Plasma levels of IL-1β and IL-6 were quantified using enzyme-linked immunosorbent assay (ELISA).

Main Results:

• Significantly elevated plasma IL-1β and IL-6 levels were observed in individuals with primary SMD and ASD compared to healthy controls.
• Both IL-1β and IL-6 levels showed a significant positive correlation with the severity of stereotyped behaviors.
• Cytokine levels were identified as significant predictors of stereotypy severity in regression analyses.

Conclusions:

• Neuroinflammatory processes, evidenced by elevated IL-1β and IL-6, appear to contribute to the pathophysiology of primary SMD and ASD.
• Increased cytokine levels are associated with more severe stereotyped behaviors.
• This study is the first to explore these neuroinflammatory markers in primary SMD, highlighting the need for further research with larger cohorts and broader inflammatory assessments.